Males versus females | 4 | <0.0001 | 2.32±0.54 | 1 | <0.0001 |
Country-status | 8 | <0.0001 | | 2 | <0.0001 |
Middle versus low | 4 | <0.0001 | 9.61±0.76 | 1 | <0.0001 |
High versus low | 4 | <0.0001 | 8.15±0.73 | 1 | <0.0001 |
High versus middle | 4 | <0.0001 | −1.47±0.60 | 1 | <0.0001 |
Neonatal screening | 12 | 0.0055 | | 3 | <0.0001 |
Not done versus result positive | 4 | 0.0024 | −3.93±0.65 | 1 | <0.0001 |
Not done versus result negative | 4 | 0.0931 | −5.41±1.18 | 1 | <0.0001 |
Not done versus result unknown | 4 | 0.0593 | −3.07±0.72 | 1 | <0.0001 |
Result positive versus result negative | 4 | 0.5407 | −1.48±1.19 | 1 | 0.2925 |
Result positive versus result unknown | 4 | 0.4819 | 0.86±0.76 | 1 | 0.1381 |
Result negative versus result unknown | 4 | 0.2139 | 2.34±1.21 | 1 | 0.1111 |
No ileus meconium versus ileus meconium | 4 | 0.7555 | 0.54±0.69 | 1 | 0.2640 |
Sweat values | 12 | 0.0937 | | 3 | <0.0001 |
Q1 versus Q2 | 4 | 0.4581 | 0.95±0.67 | 1 | 0.0339 |
Q1 versus Q3 | 4 | 0.1870 | 2.14±0.67 | 1 | <0.0001 |
Q1 versus Q4 | 4 | 0.0792 | 2.24±0.67 | 1 | <0.0001 |
Q2 versus Q3 | 4 | 0.1143 | 1.19±0.64 | 1 | 0.0034 |
Q2 versus Q4 | 4 | 0.3122 | 1.29±0.63 | 1 | 0.0013 |
Q3 versus Q4 | 4 | 0.1179 | 0.11±0.63 | 1 | 0.7922 |
Mutation | 20 | <0.0001 | | 5 | <0.0001 |
Both class I/II versus both F508del | 4 | 0.5984 | −0.18±0.61 | 1 | 0.6199 |
Both class I/II versus at least one class III | 4 | <0.0001 | −2.44±0.91 | 1 | 0.0029 |
Both class I/II versus at least one class IV | 4 | <0.0001 | −6.05±0.82 | 1 | <0.0001 |
Both class I/II versus at least one class V | 4 | <0.0001 | −5.10±0.85 | 1 | <0.0001 |
Both class I/II versus one of class I/II, other unknown | 4 | <0.0001 | −3.07±0.68 | 1 | <0.0001 |
Both F508del versus at least one class III | 4 | <0.0001 | −2.25±0.89 | 1 | 0.0045 |
Both F508del versus at least one class IV | 4 | <0.0001 | −5.87±0.80 | 1 | <0.0001 |
Both F508del versus at least one class V | 4 | <0.0001 | −4.92±0.84 | 1 | <0.0001 |
Both F508del versus one of class I/II, other unknown | 4 | <0.0001 | -2.89±0.66 | 1 | <0.0001 |
At least one class III versus at least one class IV | 4 | 0.1260 | -3.61±0.98 | 1 | 0.0002 |
At least one class III versus at least one class V | 4 | 0.0077 | -2.66±1.00 | 1 | 0.0080 |
At least one class III versus one of class I/II, other unknown | 4 | 0.0002 | -0.64±0.92 | 1 | 0.4520 |
At least one class IV versus at least one class V | 4 | 0.1625 | 0.95±0.92 | 1 | 0.2577 |
At least one class IV versus one of class I/II, other unknown | 4 | 0.0045 | 2.98±0.82 | 1 | <0.0001 |
At least one class V versus one of class I/II, other unknown | 4 | 0.9029 | 2.03±0.85 | 1 | 0.0053 |
Age at diagnosis | 11+ | <0.0001 | | 3 | <0.0001 |
<1 year versus 1–10 years | 4 | 0.0004 | −0.99±0.61 | 1 | 0.0089 |
<1 year versus 11–18 years | 4 | <0.0001 | −1.82±0.92 | 1 | 0.0331 |
<1 year versus >18 years | 4 | <0.0001 | −11.3±1.11 | 1 | <0.0001 |
1–10 years versus 11–18 years | 4 | 0.0011 | −0.84±0.92 | 1 | 0.3257 |
1–10 years versus >18 years | 4 | <0.0001 | −10.3±1.11 | 1 | <0.0001 |
11–18 years versus >18 years | 4 | 0.1509 | −9.50±1.19 | 1 | <0.0001 |